Home
News
Create
Screeners
Insights
Star Imaging And Path Lab
73.
50
+3.50
(+5.00%)
Market Cap
₹128.00 Cr
PE Ratio
6.33
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
+5.00%
1M
-6.32%
6M
-44.32%
1Y
-45.94%
5Y
-45.94%
View Company Insights
Latest news about Star Imaging And Path Lab
Star Imaging FY26 PAT rises 21% to ₹19.3 crore
6 days ago
Star Imaging and Path Lab Limited reported a 21% increase in net profit to ₹19.3 crore for FY26, with revenue rising 6% to ₹88.5 crore. EBITDA increased 17% to ₹33.2 crore, and the company utilized ₹4,053.60 lakhs of its IPO proceeds. Management guided for 25%-30% growth in FY27, with capex estimated between ₹20 crore and ₹25 crore.
Star Imaging and Path Lab Board Meeting Scheduled on May 22, 2026 to Approve FY26 Audited Financial Results
May 15, 2026
Star Imaging and Path Lab Limited Clarifies Share Price Movement to BSE
Apr 10, 2026
Star Imaging and Path Lab Limited Expands with New Diagnostic Centre in Dwarka, New Delhi
Apr 09, 2026
Star Imaging and Path Lab Limited Gets Empanelled with NIEPA for Medical Services
Jan 22, 2026
More news about Star Imaging And Path Lab
21
Jan 26
Star Imaging and Path Lab Limited Secures 5-Year Empanelment with Indian National Science Academy
Star Imaging and Path Lab Limited has secured empanelment with the Indian National Science Academy (INSA) to provide medical diagnostic and laboratory services for a five-year period. The arrangement covers medical treatment for INSA officers, employees, and their dependent family members at CGHS approved rates. The company disclosed this development on January 21, 2026, noting it represents ordinary course business that does not materially impact financial position.
21
Jan 26
Star Imaging and Path Lab Secures Delhi High Court Medical Services Contract
Star Imaging and Path Lab Limited has secured approval from the High Court of Delhi to provide credit and cashless medical services to all serving court officers and officials, including their families. The arrangement operates under CGHS norms and is part of the company's ordinary business course without material financial impact.
14
Jan 26
Star Imaging And Path Lab: CERC Selects Co For Medical Services
Star Imaging And Path Lab Limited has been empaneled by the Central Electricity Regulatory Commission (CERC) to provide medical diagnostic and laboratory services for a three-year period. The empanelment covers comprehensive medical services for CERC officers, employees, and their dependent family members at CGHS approved rates, representing a stable government sector contract for the healthcare company.
13
Jan 26
Star Imaging and Path Lab Limited Receives ICSSR Empanelment for Medical Services
Star Imaging and Path Lab Limited has been empanelled by the Indian Council of Social Science Research (ICSSR) to provide medical diagnostic and laboratory services to ICSSR pensioners, employees, and their dependents at CGHS approved rates. The two-year empanelment was disclosed on January 13, 2026, as part of regulatory compliance under SEBI Listing Regulations, with the company noting it does not constitute a material financial event.
07
Jan 26
Star Imaging and Path Lab Secures Supreme Court Medical Services Contract
Star Imaging and Path Lab Limited has received approval from the Supreme Court of India to provide credit/cashless medical services to all serving officers, officials, and their dependent family members under CGHS norms. The company disclosed this development on January 7, 2026, classifying it as ordinary business operations without material financial impact. The arrangement will be governed by applicable laws, CGHS guidelines, and internal company policies.
02
Jan 26
Star Imaging and Path Lab Secures WDRA Empanelment for Medical Services
Star Imaging and Path Lab Limited has secured empanelment with the Warehousing Development and Regulatory Authority (WDRA) Government of India for providing medical diagnostic and laboratory services to officers, employees, and their dependents at CGHS approved rates. The three-year empanelment adds to the company's existing CGHS empanelment and advanced imaging facilities including CT scan and 3 Tesla MRI at its Vikaspuri center, strengthening its position in the diagnostic healthcare sector.
Star Imaging And Path Lab
73.
50
+
3.
50
(+
5.
00
%)
1 Year Returns:
-45.94%
Industry Peers
Dr. Lal Path Labs
1,569.60
(+
0.
55
%)
Vijaya Diagnostic Centre
1,275.40
(-
3.
16
%)
Metropolis Healthcare
536.15
(-
0.
99
%)
Thyrocare Technologies
525.20
(+
0.
68
%)
Nephrocare Health Services
660.30
(-
0.
02
%)
Krsnaa Diagnostics
541.00
(-
0.
68
%)
Suraksha Diagnostic
292.40
(+
0.
74
%)
One Global Service Provider
515.40
(+
4.
99
%)
3B BlackBio DX
1,149.00
(+
3.
19
%)
Health X Platform
300.80
(-
0.
22
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar